Their findings indicate that FKA inhibits the migration, invasion, VM formation, and EMT progression of HCC cells by targeting CXCL12, thereby suppressing the PI3K/Akt/HIF-1α/Twist1 pathway (72). The gene discussed is AKT1; the disease is hepatocellular carcinoma.